“Success from the company’s perspective is having this kind of surround sound around the clinical development program that helps your program move faster to completion. I think especially for smaller biotechs time is money so as much money or as much time you can shave off definitely helps.”
– Smitha Sivaraman PhD, MBA
In this episode of Medical Affairs Unscripted, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, engages in an enlightening discussion with Smitha Sivaraman, PhD, MBA, Vice President of Medical Affairs at Verastem Oncology. Their discussion highlights the growing trend of integrating Medical Affairs into the Clinical Development process, and how this integration can streamline development when executed properly.
Dr. Sivaraman shares her insights on the expectations for Medical Affairs teams working alongside clinical development, the ideal timing for their involvement, and how their role should progress over time. They also discuss the necessary skills and qualities that Medical Affairs team members need to collaborate effectively with Clinical Development, as well as the additional training that could be advantageous. Lastly, they cover what defines success in this emerging trend.
Episode guest
Smitha Sivaraman PhD, MBA
Vice President of Medical Affairs at Verastem Oncology
